Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 4 |
GO:0005737 | cytoplasm | 2 | 4 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: E9B6G5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.453 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.430 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.456 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.451 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.428 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.475 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.597 |
CLV_PCSK_PC1ET2_1 | 111 | 113 | PF00082 | 0.435 |
CLV_PCSK_PC1ET2_1 | 135 | 137 | PF00082 | 0.389 |
CLV_PCSK_PC1ET2_1 | 14 | 16 | PF00082 | 0.428 |
CLV_PCSK_PC1ET2_1 | 23 | 25 | PF00082 | 0.444 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.597 |
CLV_PCSK_PC7_1 | 107 | 113 | PF00082 | 0.450 |
CLV_PCSK_PC7_1 | 31 | 37 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.515 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.452 |
DOC_MAPK_gen_1 | 134 | 140 | PF00069 | 0.426 |
DOC_MAPK_gen_1 | 84 | 95 | PF00069 | 0.467 |
DOC_USP7_UBL2_3 | 111 | 115 | PF12436 | 0.500 |
DOC_USP7_UBL2_3 | 130 | 134 | PF12436 | 0.396 |
DOC_USP7_UBL2_3 | 135 | 139 | PF12436 | 0.393 |
DOC_USP7_UBL2_3 | 19 | 23 | PF12436 | 0.421 |
DOC_USP7_UBL2_3 | 3 | 7 | PF12436 | 0.477 |
DOC_USP7_UBL2_3 | 9 | 13 | PF12436 | 0.481 |
LIG_14-3-3_CanoR_1 | 18 | 22 | PF00244 | 0.439 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.476 |
MOD_GlcNHglycan | 62 | 66 | PF01048 | 0.704 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.759 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.341 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.493 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.484 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.527 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.643 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.436 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.544 |
MOD_Plk_1 | 95 | 101 | PF00069 | 0.374 |
TRG_NLS_Bipartite_1 | 84 | 105 | PF00514 | 0.497 |
TRG_NLS_MonoExtN_4 | 3 | 10 | PF00514 | 0.486 |
TRG_Pf-PMV_PEXEL_1 | 6 | 10 | PF00026 | 0.468 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1S0 | Leptomonas seymouri | 81% | 100% |
A0A0S4JBT2 | Bodo saltans | 46% | 92% |
A0A1X0P5F8 | Trypanosomatidae | 54% | 95% |
A0A3Q8IIF2 | Leishmania donovani | 92% | 100% |
A0A3R7MVM6 | Trypanosoma rangeli | 54% | 100% |
A4HMV3 | Leishmania braziliensis | 80% | 100% |
A4IBH4 | Leishmania infantum | 91% | 100% |
C9ZZ68 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AFB0 | Leishmania major | 89% | 100% |